Cargando…
Synthetic promoters to induce immune-effectors into the tumor microenvironment
Harnessing the immune-system to eradicate cancer is becoming a reality in recent years. Engineered immune cells, such as chimeric antigen receptor (CAR) T cells, are facing the danger of an overt life-threatening immune response due to the ON-target OFF-tumor cytotoxicity and Cytokine Release Syndro...
Autores principales: | Greenshpan, Yariv, Sharabi, Omri, Ottolenghi, Aner, Cahana, Avishag, Kundu, Kiran, M. Yegodayev, Ksenia, Elkabets, Moshe, Gazit, Roi, Porgador, Angel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7846768/ https://www.ncbi.nlm.nih.gov/pubmed/33514819 http://dx.doi.org/10.1038/s42003-021-01664-7 |
Ejemplares similares
-
The Contribution of the Minimal Promoter Element to the Activity of Synthetic Promoters Mediating CAR Expression in the Tumor Microenvironment
por: Greenshpan, Yariv, et al.
Publicado: (2022) -
N-Glycans Mediate the Ebola Virus-GP1 Shielding of Ligands to Immune Receptors and Immune Evasion
por: Iraqi, Muhammed, et al.
Publicado: (2020) -
High throughput screen for the improvement of inducible promoters for tumor microenvironment cues
por: Sharabi, Omri, et al.
Publicado: (2022) -
Life-extended glycosylated IL-2 promotes Treg induction and suppression of autoimmunity
por: Ottolenghi, Aner, et al.
Publicado: (2021) -
Nanocomposite coatings for the prevention of surface contamination by coronavirus
por: Toledo, Esti, et al.
Publicado: (2022)